OC-13 - Safe and effective use of direct oral anticoagulants (DOAC) versus conventional anticoagulation for the treatment of cancer-related venous thromboembolism.


INTRODUCTION Cancer is a risk factor for the development of venous thromboembolism (VTE). The standard of care for the treatment of cancer-related VTE is a low molecular weight heparin (LMWH) formulation. The treatment for these events can be painful, lengthy, and expensive. The development of DOAC has created new options for the treatment of VTE. Data from… (More)
DOI: 10.1016/S0049-3848(16)30130-X


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics